J Korean Rheum Assoc.
2001 Mar;8(1):8-13.
HLA-DR4 is Not a Severity Marker in Korean Patients with Rheumatoid Arthritis
- Affiliations
-
- 1Allergy-Rheumatology Division, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Korea. byoo@www.amc.seoul.kr
- 2Allergy-Rheumatology Division, Department of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Korea.
- 3Allergy-Rheumatology Division, Department of Clinical Pathology, Asan Medical Center, University of Ulsan College of Medicine, Korea.
Abstract
OBJECTIVE
To investigate HLA-DR4,its subtype and shared epitope as a severity marker in Korean patients with rheumatoid arthritis.
METHODS
One hundred thirty-six RA patients were typed for HLA DR4 and HLA-DRB1 alleles by the polymerase chain reaction-sequence specific probe method. The patients were retrospectively evaluated for extra-articular features,presence of remission,and joint failure.Bony erosion score was assessed by Sharp's method with modification.
RESULTS
Patients with HLA-DR4 had significantly higher prevalence of extra-articular features compared to those without the allele.However,there was no association of HLA-DR4,HLA-DRB1*0405 and shared epitope with rate of remission,joint failure,and bony erosion score.Eighty-two percent of patients were rheumatoid factor positive.With seropositive patients only,the results were the same as those above.
CONCLUSION
HLA-DR4,HLA-DRB1*0405 and shared epitope are not a severity marker in Korean patients with RA in terms of radiological score,rate of joint failure,and rate of clinical remission.Data from this study do not support the clinical use of HLA-DR4 typing as a prognostic marker in Korean patients with RA.